• Medicine
  • Published in
    Current opinion in drug…
    2004

Therapeutic opportunities for liver X receptor modulators.

@article{Collins2004TherapeuticOF,
  title={Therapeutic opportunities for liver X receptor modulators.},
  author={Jon L. Collins},
  journal={Current opinion in drug discovery & development},
  year={2004},
  volume={7 5},
  pages={
          692-702
        }
}
The liver X receptors (LXRs), LXRalpha and LXRbeta, are ligand-activated transcription factors of the nuclear receptor superfamily that control the expression of genes involved in cholesterol and fatty acid metabolism. While the identification of small-molecule non-steroidal LXR agonists has validated the LXRs as potential drug targets for cardiovascular disease, recent reports from several research groups suggest that LXR ligands will be valuable therapeutic agents for the treatment of… CONTINUE READING